Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey−Holden prostate cancer academy meeting

Abstract

Introduction The 2022 Coffey−Holden Prostate Cancer Academy (CHPCA) Meeting, “Exploring New Frontiers in Prostate Cancer Research,” was held from June 23 to 26, 2022, at the University of California, Los Angeles, Luskin Conference Center, in Los Angeles, CA. Methods The CHPCA Meeting is an annual discussion‐oriented scientific conference organized by the Prostate Cancer Foundation, that focuses on emerging and next‐step topics deemed critical for making the next major advances in prostate cancer research and clinical care. The 2022 CHPCA Meeting included 35 talks over 10 sessions and was attended by 73 academic investigators. Results Major topic areas discussed at the meeting included: prostate cancer diversity and disparities, the impact of social determinants on research and patient outcomes, leveraging real‐world and retrospective data, development of artificial intelligence biomarkers, androgen receptor (AR) signaling biology and new strategies for targeting AR, features of homologous recombination deficient prostate cancer, and future directions in immunotherapy and nuclear theranostics. Discussion This article summarizes the scientific presentations from the 2022 CHPCA Meeting, with the goal that dissemination of this knowledge will contribute to furthering global prostate cancer research efforts.

Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting

“…Stuart Holden and the late Dr. Donald Coffey, this conference aims to focus discourse and debate on critical and cutting-edge topics in prostate cancer research and related fields that have considerable potential for advancing understandings of prostate cancer biology and innovative treatment approaches. [2][3][4][5][6][7][8][9][10] The 2023 CHPCA Meeting was held from June 22 to 25, 2023 at the University of California, Los Angeles, Luskin Conference Center, in Los Angeles, CA. The Meeting was themed "Disrupting Prostate Cancer Research: Challenge Accepted."…”

“…The CHPCA Meeting employs a discussion‐focused think‐tank format based on the former NCI Prouts Neck Meeting on Prostate Cancer 1 . Named in honor of prostate cancer research pioneers, Dr. Stuart Holden and the late Dr. Donald Coffey, this conference aims to focus discourse and debate on critical and cutting‐edge topics in prostate cancer research and related fields that have considerable potential for advancing understandings of prostate cancer biology and innovative treatment approaches 2–10 …”